Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 14, 2021
BioAgilytix Labs, announced that, following Australian Foreign Investment Review Board ("FIRB") approval, it officially closed the purchase of 360biolabs®. The acquisition of the company, now known as 360biolabs, a BioAgilytix company, expands ...
read more
Wednesday, November 17, 2021
BioAgilytix, a global contract research organization (CRO), announced an agreement to be further capitalized by Cinven, a leading international private investment firm focused on building world-class global companies. Cinven will acquire a majority ...
read more
BioAgilytix Labs, LLC, a global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced that it signed a definitive agreement to purchase 360biolabs®, the ...
read more
Bioanalytical Sciences, dba Inotiv, Inc. has announced that Kenneth Swart, Ph.D., has joined the Company as Vice President, Bioanalytical Sciences.
read more
BioAscent has appointed Dr. Angelo Pugliese as Associate Director of In SilicoDiscovery and Data Analysis to lead the company’s computational chemistry service.
read more
Thursday, September 03, 2020
BioAscent enhanced its service offering with a £1m/$1.3m investment in new instrumentation and equipment.
read more
Bioasis Technologies announced a joint research collaboration with a leading pharmaceutical company.
read more
Bioasis and Wuxi Biologics announced an initial strategic collaboration for the development and manufacturing of xB3-001, Bioasis’ lead investigational biological candidate to treat brain cancer.
read more
Monday, September 18, 2017
BioAxone BioSciences announced it is the recipient of a grant award from the NINDS, part of the agency's SBIR Phase II funding program.
read more
Wednesday, November 29, 2017
BIOCAD and Sothema Labs announced the launch of medicines derived using the technology provided by the Russian manufacturer into the North African market.
read more
Biocare Medical has announced a collaborative partnership with Bethyl Laboratories to develop targeted antibodies for cancer research and oncology diagnostics.
read more
Tuesday, December 17, 2024
BioCentriq has entered into a long-term lease agreement with National Business Parks for a state-of-the-art cell therapy manufacturing facility in Princeton, New Jersey. The facility will serve as the company's new headquarters and will include an ...
read more
Wednesday, February 19, 2020
Biocept has entered into an agreement with a California-based IPA to provide its liquid biopsy testing services to physicians and patients in their network.
read more
Thursday, October 07, 2021
BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the full and final transition from Hospira Adelaide ...
read more
BioCina announced it has initiated a comprehensive CMC (Chemistry, Manufacturing, and Controls) program for the advancement of RLS-2201, a proprietary injectable formulation of Quetiapine being developed by Patrys for the acute treatment of delirium ...
read more